Critical Review of Published Microarray Studies for Cancer Outcome and Guidelines on Statistical Analysis and Reporting
Tóm tắt
Từ khóa
Tài liệu tham khảo
Perez EA, Pusztai L, Van de Vijver M. Improving patient care through molecular diagnostics. Semin Oncol2004 ; 31 Suppl10: 14 –20.
Pusztai L, Symmans FW, Hortobagyi GN. Development of pharmacogenomic markers to select preoperative chemotherapy for breast cancer. Breast Cancer2005 ; 12 : 73 –85.
Simon R. Roadmap for developing and validating therapeutically relevant genomic classifiers. J Clin Oncol2005 ; 23 : 7332 –41.
Michiels S, Koscielny S, Hill C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet2005 ; 365 : 488 –92.
Ntzani EE, Ioannidis JP. Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment. Lancet2003 ; 362 : 1439 –44.
Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A1998 ; 95 : 14863 –8.
Ransohoff DF. Rules of evidence for cancer molecular-marker discovery and validation. Nat Rev Cancer2004 ; 4 : 309 –14.
Simon R, Radmacher MD, Dobbin K, McShane LM. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst2003 ; 95 : 14 –8.
Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med1990 ; 9 : 811 –8.
Korn EL, Troendle JF, McShane LM, Simon R. Controlling the number of false discoveries: application to high-dimensional genomic data. J Stat Plan Inference2004 ; 124 : 379 –98.
Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A2003 ; 100 : 9440 –5.
Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol2004 ; 159 : 882 –90.
Molinaro AM, Simon R, Pfeiffer RM. Prediction error estimation: a comparison of resampling methods. Bioinformatics2005 ; 21 : 3301 –7.
Radmacher MD, McShane LM, Simon R. A paradigm for class prediction using gene expression profiles. J Comput Biol2002 ; 9 : 505 –11.
Lusa L, McShane LM, Radmacher MD, Shih JH, Wright G, Simon R. Appropriateness of some resampling-based inference procedures for assessing performance of prognostic classifiers derived from microarray data. Stat Med 2006 ; [Epub ahead of print].
Vasselli JR, Shih JH, Iyengar SR, Maranchie J, Riss J, Worrell R, et al. Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor. Proc Natl Acad Sci U S A2003 ; 100 : 6958 –63.
Bair E, Tibshirani R. Semi-supervised methods to predict patient survival from gene expression data. PLoS Biol2004 ; 2 : E108 .
Simon R, Lam A. BRB-ArrayTools User's Guide Release 3.5, National Cancer Institute. Available at http://linus.nci.nih.gov/brb .
Kattan MW. Judging new markers by their ability to improve predictive accuracy. J Natl Cancer Inst2003 ; 95 : 634 –5.
Simon R, Korn EL, McShane LM, Radmacher MD, Wright G, Zhao Y. Design and analysis of DNA microarray investigations. New York (NY): Springer; 2004 .
Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A2001 ; 98 : 5116 –21.
Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science1999 ; 286 : 531 –7.
Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A2002 ; 99 : 6567 –72.